Silverback Therapeutics Inc (NASDAQ:SBTX)

Delayed Data
As of Nov 26
 -0.08 / -1.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Silverback Therapeutics Inc have a median target of 32.00, with a high estimate of 52.00 and a low estimate of 25.00. The median estimate represents a +343.21% increase from the last price of 7.22.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Silverback Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.69%
Growthannually 78.01%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.